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Abstract
Objectives. To determine the independent association of central adiposity, assessed by waist circumference, with
odds of psoriasis, PsA and RA prevalence after controlling for general adiposity (BMI).
Methods. A cross-sectional study of UK Biobank participants aged 4070 years was performed. Logistic regression
was used to calculate the odds of psoriasis, PsA and RA occurrence compared with controls without these conditions by
waist circumference, adjusting for covariates: age, sex, smoking status, socioeconomic deprivation and self-reported
physical activity (Model 1), followed additionally by BMI (Model 2).
Results. A total of 502 417 participants were included; 5074 with psoriasis (1.02%), 905 with PsA (0.18%), 5532 with RA
(1.11%) and 490 906 controls without these conditions. Adjusted odds ratios (ORs) (Model 1) for psoriasis, PsA and RA,
per S.D. (13.5 cm) higher waist circumference were 1.20 (95% CI 1.16, 1.23), 1.30 (95% CI 1.21, 1.39) and 1.21 (95% CI
1.17, 1.24), respectively (all P < 0.001). These ORs remained significant after further adjustment for BMI (Model 2) in
psoriasis [OR 1.19 (95% CI 1.12, 1.27), P < 0.001] and RA [OR 1.19 (95% CI 1.12, 1.26), P < 0.001], but not in PsA [OR
1.11 (95% CI 0.95, 1.29), P = 0.127].
Conclusion. Central adiposity as measured by waist circumference is associated with greater odds of psoriasis and RA
prevalence after adjustment for confounders and for BMI. Our findings add support for central adiposity as a long-term
clinically relevant component of these conditions.
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Rheumatology key messages
. Central adiposity is associated with greater odds of psoriasis and RA independently of BMI.
. These data add further insight into the relationship of body fat distribution in autoimmune disease.
. More trials assessing clinical benefits of intentional weight loss in autoimmune conditions would be beneficial.
Introduction
Observational studies have shown a positive association
between increased BMI and psoriasis and PsA incidence
[1, 2]. Recent Mendelian randomization showed that
higher BMI increased the odds of psoriasis [odds ratio
(OR) 1.09 per 1 kg/m2], with limited evidence for causality
in the opposite direction [3]. There appears to be a direct
link between adiposity and inflammation, with greater adi-
posity allele scores associated with higher CRP levels [4].
The traditional image of rheumatoid cachexia leading to
lower BMIs in RA [5] has now been somewhat expanded,
with recent studies reporting an association between
higher BMI and greater RA development [6, 7], particularly
in ACPA-negative RA [8]. Increased fat mass has been
correlated with disease activity with postulated links
through pro-inflammatory adipokine production [9].
However, other studies have shown no association be-
tween BMI and RA [10, 11], which may reflect measuring
BMI at different stages of the disease.
While BMI is often used to assess general adiposity,
evidence supports central adiposity measures, namely
waist circumference, as potentially stronger predictors of
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future cardiometabolic risk, including diabetes risk in
women [12] and stroke risk [13]. Waist circumference is
more linearly associated with incident cardiovascular dis-
ease risk than BMI, and far less subject to reverse caus-
ality [14].
No studies to date have simultaneously examined
whether individuals with psoriasis, PsA and RA have
greater central adiposity relative to those without these
conditions. We determined the independent association
of central adiposity assessed by waist circumference
with odds of psoriasis, PsA and RA occurrence after con-
trolling for general adiposity (BMI) and other confounding
factors in a large population cohort, the UK Biobank, com-
prising 500 000 subjects.
Methods
Study design and participants
The UK Biobank is a large, population-based cohort study
set up to study lifestyle, environmental and genetic deter-
minants of adulthood diseases. Between April 2007 and
December 2010, UK Biobank recruited 502 682 partici-
pants aged 4070 years from the general population.
Participants attended 1 of 22 assessment centres
across England, Wales and Scotland, where they com-
pleted touch-screen questionnaires, had physical meas-
urements taken and provided biological samples [15]. The
present study used baseline data to investigate cross-
sectional association between waist circumference and
psoriasis, PsA and RA occurrence compared with those
not reporting these outcomes. The UK Biobank study was
approved by the North West Multicentre Ethics Research
Committee; participants provided written informed con-
sent for data collection and analysis. This study is part
of UK Biobank project 3966 (NHS National Research
Ethics Service Ref 11/NW/0382).
Outcomes, exposures and covariates
Outcomes were self-reported diagnosis of psoriasis, PsA
or RA. Participants were classified as psoriasis if they re-
ported psoriasis only (and not PsA or RA), PsA if they
reported PsA or PsA and psoriasis, and RA if they re-
ported RA only (and not PsA); those who reported both
RA and PsA were omitted. The exposure variable was
waist circumference. Covariates included: age, sex,
socioeconomic deprivation index, smoking status, phys-
ical activity and BMI.
Anthropometric measurements were obtained by
trained personnel following standard operating proced-
ures and using calibrated equipment. Weight was mea-
sured, without shoes and outdoor clothing, using the
Tanita BC 418 body composition analyser. Height was
measured, without shoes, using the wall-mounted SECA
240 height measure. BMI was calculated from weight (in
kilograms) divided by square of height (in meters). Waist
circumference was measured midway between lowest rib
margin and iliac crest, in a horizontal plane, using a non-
elastic SECA 200 tape measure. Further details can be
found in the UK Biobank protocol [16].
Socioeconomic status was measured using the
Townsend deprivation score, an area of residence-
based index of material deprivation derived from census
information on housing, employment, social class and car
availability [17]. Smoking status was categorized into
never, former and current smoker. Physical activity was
based on self-report, using the International Physical
Activity Questionnaire (IPAQ) short form, and total phys-
ical activity was computed as the sum of walking, moder-
ate and vigorous activity, measured as metabolic
equivalents (MET-min/week) [18].
Statistical analysis
All analyses were performed using statistical software
STATA 14 (StataCorp LP, Texas, USA). Continuous data
were presented as mean and S.D., categorical data as
number (n) and percentage (%). Continuous variables
were checked for normality by visual inspection of histo-
grams. Logistic regression was used to calculate odds of
psoriasis, PsA and RA compared with controls per S.D.
(13.5 cm) higher waist circumference and by waist circum-
ference quintiles, adjusting for confounders: age, sex,
smoking status, socioeconomic deprivation and physical
activity (Model 1), followed additionally with adjustment
for BMI (Model 2). Waist circumference quintiles for men
were: lowest quintile 488 cm, lower-middle 88.193 cm,
middle 93.199 cm, middle-higher 99.1105 cm, highest
quintile >105 cm; for women: lowest quintile 474 cm,
lower-middle 74.180 cm, middle 80.186 cm, middle-
higher 86.195 cm, highest quintile >95 cm.
Due to the differential distribution of adipose tissue be-
tween men and women, a sex-stratified analysis was con-
ducted, with a formal interaction between waist
circumference and sex for psoriasis, PsA and RA tested
by fitting an interaction term to the model e.g.
‘waistT5#sex’. A separate sensitivity analysis was also
performed by excluding individuals with significant
comorbidities (n= 130 991) including: chronic obstructive
pulmonary disease, asthma, heart disease, chronic liver
disease, depression, alcohol misuse, substance misuse,
eating disorder, schizophrenia, Parkinson’s disease, de-
mentia and cancer.
Results
A total of 502 417 participants were included: 5074 with
psoriasis (1.02%), 905 with PsA (0.18%), 5532 with RA
(1.11%), and 490 906 controls without self-reported psor-
iasis, PsA or RA. Baseline characteristics are outlined in
Table 1. RA participants were older and predominantly
female compared with controls. Among RA individuals,
25.2% were in the most socioeconomically deprived quin-
tile, compared with 19.9% of controls. Those with psoria-
sis had the greatest percentage of current smokers
(16.3%). Mean BMI and waist circumference were higher
in men and women in all three disease groups compared
with controls. Self-reported physical activity levels were
lower in all three disease groups in men compared with
controls and in women with PsA and RA compared with
controls (Table 1).
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The adjusted ORs (Model 1) for psoriasis, PsA and RA,
per S.D. (13.5 cm) higher waist circumference were 1.20
(95% CI 1.16, 1.23), 1.30 (95% CI 1.21, 1.39) and 1.21
(95% CI 1.17, 1.24), respectively (all P < 0.001) (Fig. 1A).
These odds remained significant after further adjustment
for BMI (Model 2) in psoriasis [OR 1.19 (95% CI 1.12,
1.27), P < 0.001] and RA [OR 1.19 (95% CI 1.12, 1.26),
P < 0.001], but not in PsA [OR 1.11 (95% CI 0.95, 1.29), P
= 0.127] (Fig. 1B).
Analysis by waist circumference quintiles revealed ad-
justed ORs (Model 1) for psoriasis, PsA and RA, in the
highest compared with lowest waist circumference quin-
tiles of: 1.59 (95% CI 1.45, 1.73), 2.04 (95% CI 1.66, 2.52)
and 1.55 (95% CI 1.43, 1.69), respectively (Fig. 1A). Full
adjustment including BMI (Model 2) attenuated these ORs
to 1.35 (95% CI 1.18, 1.54), 1.41 (95% CI 1.03, 1.93) and
1.33 (95% CI 1.17, 1.52), respectively (Fig. 1B).
Sensitivity analysis excluding significant comorbidities
showed broadly similar results (supplementary Table S1,
available at Rheumatology online). There was no statistical
interaction between sex and waist circumference in psor-
iasis and RA; however, there was evidence of an inter-
action in PsA. Due to known differences in body fat
distribution between men and women, stratified analyses
by sex are presented in supplementary Figs S1 and S2,
available at Rheumatology online. The odds of psoriasis
per S.D. higher waist circumference were similar in men
and women. Associations with RA were somewhat stron-
ger for men than for women after BMI adjustment. Odds
of PsA per S.D. higher waist circumference appeared
higher in women than men, although this was not statis-
tically significant after BMI adjustment. These results
should be interpreted with caution due to the smaller
sample size and wider CIs in these smaller subgroups.
Discussion
To our knowledge, this is the first study to simultaneously
examine the role of central adiposity in psoriasis, PsA and
RA occurrence compared with controls in a large popula-
tion-based dataset. Higher waist circumferences were
associated with greater odds of psoriasis, PsA and RA,
with greatest relative odds for PsA occurrence. The asso-
ciation remained significant in psoriasis and RA after ad-
justment for general adiposity (BMI); while the point
estimate remained elevated in PsA, this was no longer
statistically significant after BMI adjustment.
The Nord-Trøndelag Health (HUNT) study reported that
psoriasis risk almost doubled in the highest compared
with lowest waist circumference quartile [1]. However,
they did not adjust for BMI, were limited to 369 incident
psoriasis cases, and had no information on PsA or RA.
The Nurses’ Health Study also showed positive associ-
ation between waist circumference and psoriasis risk
[19]. In contrast to our study, after BMI adjustment this
became non-significant. Anthropometric measurements
were, however, self-reported and based on 809 psoriasis
cases, whereas in UK Biobank all measurements were
TABLE 1 Baseline characteristics of psoriasis, PsA and RA participants compared with controls
Controls
(n=490 906)
Psoriasis
(n=5074) PsA (n=905) RA (n=5532)
Age, mean (S.D.), years 56.5 (8.1) 56.4 (8.1) 56.2 (7.4) 59.2 (7.1)
Sex, n (%)
Female 266 673 (54) 2363 (47) 464 (51) 3872 (70)
Male 224 304 (46) 2711 (53) 441 (49) 1660 (30)
Smoking status, n (%)
Current smoker 51 318 (10.5) 825 (16.3) 94 (10.4) 696 (12.6)
Ex-smoker 239 828 (49.0) 2688 (53.0) 453 (50.1) 2781 (50.4)
Non-smoker 198 582 (40.6) 1556 (30.7) 357 (39.5) 2037 (36.9)
Deprivation quintile, n (%)
1 (least) 98 555 (20.1) 933 (18.4) 178 (19.7) 975 (17.7)
2 98 002 (20.0) 931 (18.4) 192 (21.3) 959 (17.4)
3 98 131 (20.0) 1008 (19.9) 165 (18.3) 1060 (19.2)
4 98 007 (20.0) 1043 (20.6) 174 (19.3) 1138 (20.6)
5 (most) 97 601 (19.9) 1158 (22.8) 194 (21.5) 1391 (25.2)
BMI, mean (S.D.), kg/m2
Men 27.8 (4.2) 28.5 (4.6) 28.6 (4.4) 28.5 (4.7)
Women 27.1 (5.2) 27.9 (5.5) 28.9 (6.1) 28.2 (5.8)
Waist circumference, mean (S.D.), cm
Men 96.9 (11.3) 99.0 (12.0) 98.7 (11.0) 99.7 (12.1)
Women 84.7 (12.5) 86.9 (13.2) 89.2 (14.2) 87.8 (13.6)
Physical activity, mean (S.D.), total METmin/weeka
Men 2763 (3331) 2563 (3204) 2156 (2777) 2487 (3472)
Women 2321 (2801) 2230 (2794) 1977 (2682) 1935 (2748)
aMetabolic equivalent task (MET) min/week.
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made by trained personnel in >5000 individuals with
psoriasis.
While some studies have suggested that obesity was
associated with over triple the odds of developing RA
[20], others have shown no increased risk [10]. Meta-
analysis of 11 studies revealed that compared with
those with a BMI <30 kg/m2, those who were obese
had a significantly increased risk of RA (relative risk
1.25, 95% CI 1.07, 1.45); however, there was significant
heterogeneity between studies [21]. By using waist cir-
cumference and adjusting for BMI, we have shown an
association between this central adiposity marker and
higher odds of RA occurrence. While this study is
cross-sectional and cannot demonstrate causality, it
may be that waist circumference rises in those with
prevalent disease due to the disease process itself, or
those with greater central adiposity are more prone to
developing autoimmune disease.
Obesity is associated with increased PsA risk [2]; our
results confirm this, with the strongest association be-
tween higher waist circumference and PsA out of the
three conditions studied. After BMI adjustment, this asso-
ciation was no longer statistically significant. However, the
PsA group was considerably smaller than psoriasis and
RA groups, reducing the ability to detect significant asso-
ciations in adjusted analyses.
Stratified analyses by sex showed similar associations
in psoriasis in men and women, with the suggestion of a
stronger association of waist circumference with PsA in
women. However, this latter result should be interpreted
with caution due to smaller sample size and wider CIs in
this group. Associations with RA appeared stronger in
men after BMI adjustment. Such sex differences were
also noted by Ljung et al. who showed an >3-fold
increased risk of developing RA in men with abdominal
obesity (waist circumference >102 cm) [22].
Study strengths include robust measurement of waist
circumference and BMI and the large sample size of the
UK Biobank, one of the largest studies to simultaneously
examine central adiposity in psoriasis, PsA and RA com-
pared with controls. Sensitivity analysis excluding signifi-
cant comorbidities demonstrated the robustness of
results. Limitations include the cross-sectional study
design. The UK Biobank is not entirely representative of
the whole UK population, with evidence of a healthy vol-
unteer selection bias [23]. This may partly explain the
lower prevalence of psoriasis in this study (1.02%) com-
pared with that reported in other studies such as the UK
Clinical Practice Research Datalink (CPRD) (reported
psoriasis prevalence 2.8%) [24]. Potential misclassifica-
tion bias due to the self-reported nature of diagnoses
may potentially have led to over-reporting of RA in the
UK Biobank (prevalence 1.11%), compared with that re-
ported by Symmons et al. [25] (estimated RA prevalence
0.81% in UK). However, the valid assessment of expos-
uredisease relationships in UK Biobank is still widely
generalizable [23].
In conclusion, higher waist circumference was asso-
ciated with higher odds of psoriasis, PsA and RA preva-
lence compared with controls. Importantly, this remained
significant in psoriasis and RA after BMI adjustment, high-
lighting the potential importance of central adiposity in
these autoimmune conditions. This is the largest study
to examine such associations and, given established
links of central adiposity to adverse cardiometabolic out-
comes [12, 14], suggests better understanding of the link
between altered body composition and risk for autoim-
mune conditions is needed. The potential for autoimmune
processes to lead to altered body composition should
also be borne in mind. Either way, our findings add stron-
ger support for central adiposity as a relevant player in the
long-term complications of these conditions. They also
FIG. 1 Odds of psoriasis, PsA, and RA with increasing waist circumference
(A) Odds of psoriasis, PsA and RA adjusted for: age, sex, socioeconomic deprivation quintile, smoking status and
physical activity (Model 1). (B) Odds of psoriasis, PsA and RA fully adjusted for the above covariates plus BMI (Model 2).
Waist circumference quintiles for men: lowest quintile 488 cm, lower-middle 88.193 cm, middle 93.199 cm, middle-
higher 99.1105 cm, highest quintile >105 cm. Waist circumference quintiles for women: lowest quintile474 cm, lower-
middle 74.180 cm, middle 80.186 cm, middle-higher 86.195 cm, highest quintile >95 cm.
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suggest a need to consider more trials of weight loss
interventions in autoimmune conditions, especially as
the evidence base for lifestyle-induced weight loss has
substantially improved in recent years.
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An atypical presentation of subacute cutaneous
lupus erythematous
A 60-year-old lady with chronic undifferentiated connective
tissue disease (UCTD) presented to clinic after developing a
widespread rash. This rash started 4 months prior to this ap-
pointment and has a combination of maculopapular and papu-
losquamous patterns, manifesting at the upper thorax before
dissemination. Annular erythematous plaques were present at
the lower limbs (Fig. 1) as well as the upper body. There was
involvement of the face and scalp. The patient complained of
mild skin blistering but was otherwise without systemic symp-
toms. There was no marked recent sun exposure and she
was taking hydroxychloroquine for UCTD. Other medications
include levothyroxine, lisinopril and bisoprolol. Haematology
and blood film revealed lymphopenia (lymphocytes
0.4109 cells/l). Lupus and systemic sclerosis screening re-
turned negative. Skin biopsy of the left anterior thigh displayed
epidermal atrophy and hydropic degeneration of the basal
layer. Oral prednisolone 15 mg/daily for 4 weeks was initiated
and dermatological improvements were observed. Subacute
cutaneous lupus erythematous has annular and papulosqua-
mous morphological variants but is frequently diagnosed with
features of both [1]. It associates with young to middle aged
females and the majority of patients have abnormal photo-
sensitivity [1, 2]. Classically, lesions do not occur below the
waist with sparing of facial and scalp areas [2].
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FIG. 1 Subacute cutaneous lupus erythematous at the lower limbs
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